# Is Adaptive SBRT for Prostate vs Image-guided Radiotherapy a True Evolution (ASPIRE)

> **NCT06825091** · PHASE3 · RECRUITING · sponsor: **University Health Network, Toronto** · enrollment: 320 (estimated)

## Conditions studied

- Localized Prostate Cancer
- Stereotactic Body Radiotherapy

## Interventions

- **RADIATION:** SBRT

## Key facts

- **NCT ID:** NCT06825091
- **Lead sponsor:** University Health Network, Toronto
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-02-04
- **Primary completion:** 2030-02-04
- **Final completion:** 2030-02-04
- **Target enrollment:** 320 (ESTIMATED)
- **Last updated:** 2026-01-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06825091

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06825091, "Is Adaptive SBRT for Prostate vs Image-guided Radiotherapy a True Evolution (ASPIRE)". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06825091. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*